Brazil Blood Disorder Therapeutics Market valued at $335 Mn in 2022, projected to reach $643 Mn by 2030 with a 8.5% CAGR. Rising prevalence of blood diseases, advanced therapies, and increased healthcare investment are driving the growth of the Brazil Blood Disorder Therapeutics Market. The Brazil market encompasses various players across different segments, including Pfizer, Sanofi, Novartis, Takeda Pharmaceuticals, CSL Behring, Alexion, Eurofarma, Hypera Pharma, Neo Quimica, Cristalia etc, among various others.














